Olympus Corp. Company Profile (OTCMKTS:OCPNY)

Analyst Ratings

Consensus Ratings for Olympus Corp. (OTCMKTS:OCPNY) (?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for Olympus Corp. (OTCMKTS:OCPNY)
No equities research coverage for this company has been tracked by MarketBeat.com


Earnings History for Olympus Corp. (OTCMKTS:OCPNY)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
2/7/2014Q4$0.42ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)


Earnings Estimates for Olympus Corp. (OTCMKTS:OCPNY)
No earnings estimates for this company have been tracked by MarketBeat.com


Dividend History for Olympus Corp. (OTCMKTS:OCPNY)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Olympus Corp. (OTCMKTS:OCPNY)
No insider trades for this company have been tracked by MarketBeat.com


Latest Headlines for Olympus Corp. (OTCMKTS:OCPNY)
07/20/16 08:30 PMOlympus Eyes M&A in Ongoing Recovery -
07/14/16 08:30 AMThe Zacks Analyst Blog Highlights: Honda Motor, Toyota Motor, Canon and Olympus -
05/06/16 07:00 AMOlympus Corporation of the Americas Enters Into US And Canada Distribution Agreement With Arc Medical Design Ltd, A Subsidiary Of Norgine For ENDOCUFF VISION® - [PR Newswire] - CENTER VALLEY, Pa., May 6, 2016 /PRNewswire/ -- Olympus Corporation of the Americas today announced a new distribution agreement with Norgine B.V. and its subsidiary Arc Medical Design Ltd. by which Olympus Corporation of the Americas becomes the exclusive distributor of ENDOCUFF VISION® in the U.S. and Canada. The ENDOCUFF VISION® will be showcased at the adjoining Arc and Olympus booths at the Digestive Disease Week (DDW) conference in San Diego, Calif. May 22-26, 2016.
05/04/16 09:38 AMOlympus Corp. :OCPNY-US: Earnings Analysis: Q4, 2016 By the Numbers -
04/15/16 05:00 PMReport: More infections from dirty scopes than estimated -
04/09/16 09:26 PM[video]Olympus Teams Up With Sony for Surgical Big Screen TV -
03/25/16 05:04 AMOlympus sought price hike for UCLA amid superbug outbreak - Soon after doctors at UCLA's Ronald Reagan Medical Center traced deadly infections to tainted medical scopes last year, they pressed the device maker to lend them replacements. But Olympus Corp. refused. Instead, the Tokyo company offered to sell UCLA 35 new scopes for $1.2 million — a 28% increase...
03/04/16 04:45 PMWhistleblower Delivers A Triple Whammy To Olympus; More Companies Might Get Hit -
03/02/16 01:40 PMWhistleblower wins $51 million in kickback and bribery case - A whistleblower will collect a $51 million payday after sounding the alarm about bribes and kickbacks at the medical device company where he worked. Olympus Corporation of the Americas agreed Tuesday to pay $646 million in fines after it admitting to a ...
03/01/16 01:20 PMOlympus to pay at least $635 million to settle kickback and bribery cases - Olympus Corp., a leading manufacturer of medical scopes, will pay at least $635 million to resolve separate criminal and civil investigations into kickbacks and foreign bribery. The Tokyo-based company announced Tuesday that its U.S. unit will pay $612 million plus interest to end the kickback...
03/01/16 12:58 PMOlympus to pay at least $646 million to end US probes -
03/01/16 09:27 AMOlympus Will Pay $646 Million to End Kickback, Bribe Probes -
02/18/16 01:34 AMOlympus settles with Japan whistleblower after 8-year battle -
02/10/16 10:39 AMOlympus Corp. Earnings Analysis: Q3, 2016 By the Numbers -
01/17/16 06:57 PMFDA Approves Fixes for Olympus Scope Linked to Infections - The U.S. Food and Drug Administration cleared a modified version of a device manufactured by Olympus Corp. OCPNY-3.62 % that was linked to so-called superbug infections. As a result of the approval, the camera and medical-equipment maker plans to ...
01/15/16 12:04 PMOlympus to recall and redesign medical scope linked to superbug outbreaks - Olympus Corp. said it will voluntarily recall and redesign a troubled medical scope that has been linked to scores of potentially deadly patient infections around the world. The company, which sells about 85% of the duodenoscopes used in the United States, said it will redesign an internal mechanism...
01/15/16 11:59 AMEx-Olympus CEO Woodford Sues Company for Breach of Contract -
12/23/15 03:00 PM​Congressman wants SEC probe into Olympus over superbug outbreak -
12/14/15 01:20 PMMedtronic-Samsung to Advance Neuromodulation Therapy -
12/14/15 12:20 PMBecton, Dickinson Unveils BD FACSCelesta Flow Cytometer -
12/14/15 12:10 PMSt. Jude Medical Unveils Positive Data from SUNBURST Study -
12/11/15 01:10 PMFDA OKs Medtronic Activa DBS System for Full-Body MRI Scan -
12/10/15 01:15 PMEdwards Lifesciences Reveals 2016 and Long-Term Outlook -
12/10/15 12:00 PMathenahealth Unveils 2016 Outlook; 2015 Projections Intact -
12/09/15 11:50 AMBecton, Dickinson IV Solution to Aid Medication Management -
12/08/15 08:50 AMAllscripts (MDRX) Rides High on Partnerships, Customer Wins -
12/07/15 03:45 PMCerner's HealtheIntent on a Roll: Wins a String of Contracts -
12/07/15 03:05 PMSt. Jude Receives CE Mark for MRI on Quadra Assura CRT-D -
12/04/15 09:10 AMCooper Companies Q4 Earnings, Revenues Lag; Stock Down -


About Olympus Corp.

Olympus Corp. logoOlympus Corporation is engaged in the manufacture and sale of precision machineries and instruments. The Company's segments include Medical Business, Scientific Solutions Business, Imaging Business and Others. The Company's Medical Business manufactures and sells medical endoscopes, surgical endoscopes, endotherapy devices and other products. Its Scientific Solutions Business manufactures and sells biological microscopes, industrial microscopes, industrial endoscopes, non-destructive testing equipment and other products. Its Imaging Business manufactures and sells digital cameras, voice recorders and other products. Its Others Business manufactures and sells biomedical materials, conducts system development and other business activities. Its technologies include optical technologies, electronic imaging technologies, precision technologies and biological based technologies. It has a service network consisting of over 200 sites on approximately six continents.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: N/A
  • Sub-Industry: N/A
  • Exchange: OTCMKTS
  • Symbol: OCPNY
  • CUSIP:
Key Metrics:
  • Previous Close: $34.46
  • 50 Day Moving Average: $36.86
  • 200 Day Moving Average: $38.06
  • P/E Ratio: 19.91
  • P/E Growth: 0.00
  • Market Cap: $11.79B
  • Beta: 0.31
  • Current Year EPS Consensus Estimate: $1.17 EPS
  • Next Year EPS Consensus Estimate: $1.69 EPS
Additional Links:
Olympus Corp. (OTCMKTS:OCPNY) Chart for Saturday, July, 30, 2016